ARTICLE | Company News
Ablexis deal
July 16, 2012 7:00 AM UTC
Ablexis granted an undisclosed pharmaceutical company non-exclusive rights to AlivaMab Mouse transgenic mouse technology to discover human antibodies. The pharma will make a "seven-figure pre-delivery...